The FDA is reminding healthcare professionals that intravenous Tygacil (tigecycline, from Pfizer) can increase mortality risk in the treatment of serious bacterial infections.

The FDA has warned consumers not to take TimeOut Capsules, which are marketed as a dietary supplement for sexual enhancement.

Glow Industries and the FDA have notified consumers of a voluntary nationwide recall of Mr. Magic Male Enhancer from Don Wands.

The FDA has notified healthcare professionals that clinical trial data suggesting that Stalevo (carbidopa, levodopa, entacapone, from Novartis) increases the risk for cardiovascular events compared to carbidopa/levodopa (Sinemet, from Bristol-Myers Squibb) is being evaluated.

The FDA has issued a Proposal to Withdraw Marketing Approval for ProAmatine (midodrine HCl, from Shire), used in the treatment of orthostatic hypotension, because required post-approval studies that verify the clinical benefit of the drug have not been done.

Prolatis' and the FDA announced a nationwide voluntary recall of its product Prolatis' after lab analysis found the product to contain undeclared sulfoaildenafil.

The FDA has informed healthcare professionals and patients that Lamictal (lamotrigine, from GlaxoSmithKline) can cause aseptic meningitis.

Novacare LLC and the FDA have announced a nationwide voluntary recall of products sold under the following names: Stiff Nights, Aziffa, Size Matters, Erex, Mojo, Hard Drive, Eyeful, Red Magic, Straight Up, Zotrex, Monster Excyte, WOW, Xaitrex, Verect, Prolatis, Xytamax, Maxyte, Libidinal, OMG, OMG45, and Zilex (with Golden Spear).

EZVille and the FDA announced a recall of all lots of Revivexxx Extra Strength, marketed as a dietary supplement sexual enhancer for men, after FDA lab analyses found the product to contain undeclared tadalafil.

EZVille and the FDA announced a recall of all lots of Solo Slim and Solo Slim Extra Strength capsules after FDA lab analyses showed the products to contain undeclared didesmethyl sibutramine.